News and Trends 20 Jun 2023
Clearance for anti-tumor bispecific antibody trial
TG ImmunoPharma Co., Ltd. (TGI), which focuses on the development of novel immuno-oncology therapies, says the FDA has granted clearance for the clinical trial of TGI-6, its bispecific antibody. TGI-6…